NCT07641530

Brief Summary

This study evaluates the effect of a Health Belief Model (HBM)-based educational intervention on pruritus severity and pruritus-related quality of life (QoL) in hemodialysis patients. The cluster-randomized controlled trial includes hemodialysis patients allocated to an intervention group and a control group. The intervention group receives two face-to-face HBM-based education sessions at 15-day intervals supported by a structured booklet, while the control group receives standard care. Pruritus outcomes and quality of life are assessed using the 5-D Itch Scale and ItchyQoL to determine the effectiveness of theory-driven educational frameworks in routine nursing care and patient-centered outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 8, 2026

Last Update Submit

June 10, 2026

Conditions

Keywords

Quality of LifePatient EducationHealth Belief Model

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Pruritus Severity on the 5-D Itch Scale

    The 5-D Itch Scale is used to measure the multidimensional aspects of pruritus (duration, degree, direction, disability, and distribution). Total scores range from 5 (no itch) to 25 (most severe itch), where higher scores indicate greater pruritus severity.

    Baseline and Day 45

Secondary Outcomes (1)

  • Change from Baseline in Pruritus-Related Quality of Life on the ItchyQoL Scale

    Baseline and Day 45

Study Arms (2)

Intervention Group

EXPERIMENTAL

This group receives two face-to-face Health Belief Model (HBM)-based education sessions at 15-day intervals supported by a structured booklet.

Behavioral: Health Belief Model-Based Education

Control Group

NO INTERVENTION

This group receives standard routine care without any specific educational intervention.

Interventions

The intervention consists of a theory-based educational program focused on chronic kidney disease-associated pruritus symptom management, structured according to the Health Belief Model (HBM). Patients receive two face-to-face education sessions conducted at 15-day intervals, supported by a structured educational booklet. Data collection is performed twice, at baseline and on day 45, using a descriptive information form, the 5-D Itch Scale, and the ItchyQoL scale.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Diagnosed with end-stage renal disease requiring maintenance hemodialysis for at least 3 months
  • Experienced CKD-associated pruritus during the previous 2 weeks

You may not qualify if:

  • Use of antihistamines within the past month
  • Conditions that could limit participation in the educational intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University, Ataturk Vocational School of Health Services

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pruritus

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the face-to-face nature of the educational intervention, blinding of the participants and the educator was not feasible.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a cluster-randomized controlled trial where hemodialysis patients are allocated to the intervention and control groups based on treatment day clusters.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, PhD

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 11, 2026

Study Start

January 1, 2022

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations